Mankind Pharma Limited (NSE:MANKIND)
2,443.70
+37.20 (1.55%)
Oct 29, 2025, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.01 trillion as of October 29, 2025. Its market cap has decreased by -6.30% in one year.
Market Cap
1.01T
Enterprise Value
1.07T
Revenue
129.10B
Ranking
n/a
PE Ratio
52.65
Stock Price
2,443.70
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.01T, an increase of 77.03%. That is a compound annual growth rate of 25.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 993.30B | -16.41% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.27T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Fortis Healthcare | 797.99B |
| Alkem Laboratories | 649.48B |
| Aurobindo Pharma | 638.53B |